Stock Events

PTC Therapeutics (BH3.F) Q3 2022 Earnings

4AugConfirmed
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-2.08
-1.81
-1.53
-1.26

Details

Expected EPS
-1.366134
Actual EPS
-2.0784752999999996
Surprise EPS
-0.71
Surprise Percent
+52.14%

Description

PTC Therapeutics (BH3.F) has reported earnings of -2.0784752999999996 per share for Q3 2022.

0 Comments

Share your thoughts